QDEL QuidelOrtho Corporation

NASDAQ
$12.84

QuidelOrtho Corporation (QDEL) is expected to report earnings on February 2, 2027, after the market close. The consensus earnings estimate is $0.47 per share, and the stock has had a Post-Earnings Announcement Drift (PEAD) of -12.1% since its last earnings release on November 3, 2026.

QuidelOrtho Missed Consensus Estimates, Narrows Guidance
Tuesday, November 3, 2026 · 4:05 PM ET
Earnings Date
4th Quarter, Dec 2026
Feb 2
Tuesday · 4:05 PM ET
Earnings Whisper
-
vs $0.47 (GAAP)
Volatility
Enter your expectations below to reveal the current volatility.
Trend Analysis
Expectation
Earnings
Price action
Signals
Score
Sentiment
Grade
Life Cycle
Call Analysis
Earnings-AVWAP $13.51

Sign in or subscribe to unlock sentiment, short interest, and technical indicators.

About QuidelOrtho Corporation

Quidel Corporation is a leading manufacturer of diagnostic solutions at the point of care, delivering a continuum of rapid testing technologies that further improve the quality of health care throughout the globe.

Sector

Healthcare

Industry

Diagnostic Substances

Held By 2 ETFs, by dollar flow

Charts powered in part by Lightweight Charts™ by TradingView.